000 | 01891 a2200613 4500 | ||
---|---|---|---|
005 | 20250517191305.0 | ||
264 | 0 | _c20180720 | |
008 | 201807s 0 0 eng d | ||
022 | _a0973-7138 | ||
024 | 7 |
_a10.1007/s12038-017-9706-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSarmah, N P | |
245 | 0 | 0 |
_aAntifolate drug resistance: Novel mutations and haplotype distribution in _h[electronic resource] |
260 |
_bJournal of biosciences _cDec 2017 |
||
300 |
_a531-535 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntimalarials _xpharmacology |
650 | 0 | 4 |
_aArtemisinins _xpharmacology |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aContraindications, Drug |
650 | 0 | 4 |
_aDihydropteroate Synthase _xgenetics |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 |
_aDrug Resistance _xgenetics |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aHaplotypes |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndia _xepidemiology |
650 | 0 | 4 |
_aMalaria, Falciparum _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aPlasmodium falciparum _xdrug effects |
650 | 0 | 4 |
_aProtozoan Proteins _xgenetics |
650 | 0 | 4 |
_aPyrimethamine _xpharmacology |
650 | 0 | 4 |
_aSulfadoxine _xpharmacology |
650 | 0 | 4 |
_aTetrahydrofolate Dehydrogenase _xgenetics |
700 | 1 | _aSarma, K | |
700 | 1 | _aBhattacharyya, D R | |
700 | 1 | _aSultan, A A | |
700 | 1 | _aBansal, D | |
700 | 1 | _aSingh, N | |
700 | 1 | _aBharti, P K | |
700 | 1 | _aSehgal, R | |
700 | 1 | _aMohapatra, P K | |
700 | 1 | _aParida, P | |
700 | 1 | _aMahanta, J | |
773 | 0 |
_tJournal of biosciences _gvol. 42 _gno. 4 _gp. 531-535 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12038-017-9706-5 _zAvailable from publisher's website |
999 |
_c27878501 _d27878501 |